Full Target Library

Built on the proprietary RenMice^® platform, Biocytogen's antibody library offers access to 1,000+ druggable targets and over one million experimentally validated, fully human antibody sequences, providing partners with a highly reliable and efficient source of discovery-ready molecules.

This comprehensive library supports the development of diverse therapeutic modalities—including bispecific antibodies, multispecific antibodies, ADCs, VHHs, oligonucleotide-based therapies, and cell therapies—with broad applications across oncology, autoimmune, metabolic, and neurological diseases.